Althea Stillman

Direktor/Vorstandsmitglied bei Innervace, Inc.

Consumer Services

Health Technology

Profil

Althea Stillman is currently a Director at Innervace, Inc. Previously, she worked as a Director at CTx Operations, Inc. She holds a doctorate degree from Yale University and an undergraduate degree from the University of California, Berkeley.

Aktive Positionen von Althea Stillman

Unternehmen	Position	Beginn
Innervace, Inc. Innervace, Inc. BiotechnologyHealth Technology Innervace, Inc. is an American regenerative therapy company that develops technology to replace lost connections due to brain degeneration or injury. The company is based in Philadelphia, PA. The company's lead program focuses on mimicking the lost nigrostriatal pathway in patients with Parkinson's disease. The company was founded by Kacy Cullen and Douglas Smith, and the CEO is Nader Halim.	Direktor/Vorstandsmitglied	-

Alle aktiven Positionen von Althea Stillman

Ehemalige bekannte Positionen von Althea Stillman

Unternehmen	Position	Ende
CTx Operations, Inc. CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA.	Direktor/Vorstandsmitglied	-

Sehen Sie sich die Erfahrung von Althea Stillman im Detail an

Ausbildung von Althea Stillman

University of California, Berkeley	Undergraduate Degree
Yale University	Doctorate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Althea Stillman im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	2
CTx Operations, Inc. CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA.	Health Technology
Innervace, Inc. Innervace, Inc. BiotechnologyHealth Technology Innervace, Inc. is an American regenerative therapy company that develops technology to replace lost connections due to brain degeneration or injury. The company is based in Philadelphia, PA. The company's lead program focuses on mimicking the lost nigrostriatal pathway in patients with Parkinson's disease. The company was founded by Kacy Cullen and Douglas Smith, and the CEO is Nader Halim.	Health Technology